Open Access
ARTICLE
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways
* Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
† Department of NEUROFARBA, University of Florence, Florence, Italy
‡ Department of Health Sciences, University of Florence, Florence, Italy